With Circular E.2023/2023, the Independent Authority of Public Revenue (“IAPR”) has eventually shed light on the income tax treatment of VAT corresponding to rebates refunded to pharmaceutical companies, in cases where such VAT had been deducted for income tax purposes in previous fiscal years.
Source PwC
Latest Posts in "Greece"
- AADE Automates Majority of VAT and Activity Code Changes for Faster Processing
- Greece Enacts Mandatory B2B E-Invoicing Law for Domestic and Cross-Border Transactions
- Administrative Support Services Subject to VAT When Not Closely Linked to Social Welfare
- Greek Parliament Approves Mandatory B2B E-Invoicing Bill, Implementation Expected by 2027
- Greece Establishes Mandatory B2B E-Invoicing Law, Awaiting Technical Details and Implementation Date
